grepcent public filings, reorganized for comparison

VTAMA — FDA application NDA215272

Application NDA215272 · type NDA · FDA status: approved · original approval 2022-05-23

Listed sponsor: ORGANON LLC · OGN company profile · exact_unique

Sponsor as listed in Drugs@FDA at retrieval (2026-08-07); FDA sponsor listings can lag ownership transfers.

FDA application facts

ProductFDA-listed trade nameActive ingredientDosage formRouteStrengthMarketing statusTE codeRLD
001VTAMATAPINAROFCREAMTOPICAL1%Prescriptionnot listedYes

Product, form, strength, reference-drug and marketing-status fields: Drugs@FDA data files; TE and RLD fields: Orange Book data files. Retrieved 2026-08-07.

Orange Book patent and exclusivity listings

ListingProductDescriptive dateFlags/code
Patent 10426743001listed patent expiry date: 2036-05-19U-4048
Patent 10426743001listed patent expiry date: 2036-05-19U-2625
Patent 11458108001listed patent expiry date: 2036-05-19drug product
Patent 11612573001listed patent expiry date: 2036-05-19U-4048
Patent 11612573001listed patent expiry date: 2036-05-19U-2625
Patent 11617724001listed patent expiry date: 2036-05-19drug product
Patent 11622945001listed patent expiry date: 2036-05-19drug product
Patent 10195160001listed patent expiry date: 2036-05-23drug product
Patent 10647649001listed patent expiry date: 2038-11-13drug substance
Patent 11597692001listed patent expiry date: 2038-11-13drug substance, drug product
Patent 11497718001listed patent expiry date: 2039-11-13U-4048
Patent 11590088001listed patent expiry date: 2039-11-13U-2625
Patent 11938099001listed patent expiry date: 2039-11-13U-4048
Patent 12569453001listed patent expiry date: 2039-12-18U-4048
Exclusivity NCE001listed exclusivity date: 2027-05-23FDA code as listed
Exclusivity I-956001listed exclusivity date: 2027-12-12FDA code as listed
NDA215272 FDA listing dates. Source: Drugs@FDA and FDA Orange Book.NDA215272 FDA listing dates. Source: Drugs@FDA and FDA Orange Book.NDA215272 FDA listing datesDescriptive regulatory dates only; no relationship to revenue or future sales is stated or implied.Source: Drugs@FDA and FDA Orange Book.Listed dateDated listing marker0.001.002.002022-05-231.002027-05-231.002027-12-121.002036-05-191.002036-05-231.002038-11-131.002039-11-131.002039-12-181.00

Patent and exclusivity dates are regulatory listings from the FDA Orange Book; no relationship to revenue or future sales is stated or implied.

Compound cross-links

Ingredient–compound links use FDA openFDA/GSRS identifiers and an exact lmmol InChIKey join. Ingredient names cannot create a link.

Related pages

Sponsor company · FDA-approved application index

Peer clusters: No published peer-cluster link for this sponsor.

Sources: Drugs@FDA · Orange Book · openFDA application record. FDA data retrieved 2026-08-07.

Regulatory listing data as published by FDA; not medical or investment advice.